SB-505124

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameSB-505124
Drug Alias NameSB-505124
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor-like kinase 4 inhibitorsTransforming growth factor beta receptor 1 inhibitorsActivin receptor type-1C inhibitors
TargetsActivin receptor-like kinase 4Transforming growth factor beta receptor 1Activin receptor type-1C
Therapy Area/IndicationsCicatrix
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsCicatrix

Other Information

ATC CodeN/A
Related LinksN/A